Captain T Cell Secures Seed Financing Round Totaling € 8.5 Million
I&i Biotech Fund I SCSp, Brandenburg Kapital GmbH and HIL-INVENT Ges.m.b.H. participated in the seed roundFunds will be used to accelerate a new generation of T cell therapies against solid
Source: smdailyjournal.com